[Coronary angiography in chronic and acute coronary artery disease. Advantages of a low osmolality contrast medium].
The advantages of a new low osmolality contrast medium (sodium meglumine ioxaglate) in clinical coronary angiography are demonstrated at two groups of patients in comparison to sodium meglumine diatrizoate. One group included patients undergoing diagnostic angiography in chronic state of CHD, the other during diagnosis and therapy (intracoronary lysis) in state of acute myocardial infarction. Injection of the low osmolality contrast material was followed in both groups by significant reduction of pressure drop and cardiac slowing. In both groups there was also a reduction of changes in ECG compared to side effects of the conventional contrast material.
D000368:Aged; D000792:Angiography; D001794:Blood Pressure / Q000187:drug effects; D003287:Contrast Media / Q000494:pharmacology*; D017023:Coronary Angiography; D003327:Coronary Disease / Q000000981:diagnostic imaging*; D003974:Diatrizoate Meglumine; D004562:Electrocardiography; D006801:Humans; D007485:Ioxaglic Acid; D008875:Middle Aged; D009994:Osmolar Concentration; D014283:Triiodobenzoic Acids
D003287:Contrast Media; D014283:Triiodobenzoic Acids; D003974:Diatrizoate Meglumine; D007485:Ioxaglic Acid
Koronarangiographie im chronischen und akuten Stadium der koronaren Herzkrankheit. Vorteile eines niederosmolaren Kontrastmittels.